These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15601447)

  • 41. Drug development for use by the aquaculture industry: the producers' perspective.
    MacMillan JR
    Vet Hum Toxicol; 1998; 40 Suppl 2():7-9. PubMed ID: 9823575
    [No Abstract]   [Full Text] [Related]  

  • 42. Rationale for compounding commercially available products.
    Murry T
    Am J Vet Res; 2009 Nov; 70(11):1307; author reply 1307-8. PubMed ID: 19878010
    [No Abstract]   [Full Text] [Related]  

  • 43. Bioidentical hormone therapy: a panacea that lacks supportive evidence.
    Boothby LA; Doering PL
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):400-7. PubMed ID: 18660693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Panel report: AVMA colloquium on clinical pharmacology.
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1045-8. PubMed ID: 7216869
    [No Abstract]   [Full Text] [Related]  

  • 45. Veterinary pharmacology: a look into the future.
    Mills PC; Higgins A
    Vet J; 2007 Nov; 174(3):447-8. PubMed ID: 17967554
    [No Abstract]   [Full Text] [Related]  

  • 46. What can the veterinary profession expect in Obama's America? AVMA ready to work with new administration. Interview by Scott Nolen.
    Lutschaunig M
    J Am Vet Med Assoc; 2009 Jan; 234(2):183-4, 186. PubMed ID: 19226692
    [No Abstract]   [Full Text] [Related]  

  • 47. Critical evaluation of scientific articles and other sources of information: an introduction to evidence-based veterinary medicine.
    Kastelic JP
    Theriogenology; 2006 Aug; 66(3):534-42. PubMed ID: 16720037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Veterinary pharmacovigilance. Part 6. Predictability of adverse reactions in animals from laboratory toxicology studies.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):213-31. PubMed ID: 15842309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scientific authorship. Part 2. History, recurring issues, practices, and guidelines.
    Claxton LD
    Mutat Res; 2005 Jan; 589(1):31-45. PubMed ID: 15652225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The future of veterinary therapeutics: a glimpse towards 2030.
    Riviere JE
    Vet J; 2007 Nov; 174(3):462-71. PubMed ID: 17825591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compounding in veterinary anesthesiology.
    Hubbell JA
    J Am Vet Med Assoc; 1994 Jul; 205(2):202-4. PubMed ID: 7928575
    [No Abstract]   [Full Text] [Related]  

  • 52. Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora.
    Cerniglia CE; Kotarski S
    J Vet Pharmacol Ther; 2005 Feb; 28(1):3-20. PubMed ID: 15720510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guide for peer reviewers of scientific articles in the Croatian Medical Journal.
    Marusić M; Sambunjak D; Marusić A
    Croat Med J; 2005 Apr; 46(2):326-32. PubMed ID: 15849858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FDA-approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy.
    Almeida JI; Raines JK
    Dermatol Surg; 2007 Sep; 33(9):1037-44; discussion 1044. PubMed ID: 17760594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HOD wants better communication with nonveterinary pharmacies.
    Larkin M
    J Am Vet Med Assoc; 2012 Sep; 241(6):678. PubMed ID: 23110284
    [No Abstract]   [Full Text] [Related]  

  • 56. Food and Drug Administration approval process for ophthalmic drugs in the US.
    Lloyd R; Harris J; Wadhwa S; Chambers W
    Curr Opin Ophthalmol; 2008 May; 19(3):190-4. PubMed ID: 18408492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formation of the American College of Veterinary Pharmacology and Therapeutics.
    Short CR
    Vet Med Small Anim Clin; 1977 May; 72(5):812. PubMed ID: 586044
    [No Abstract]   [Full Text] [Related]  

  • 58. Comments on European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications.
    Foote M; Hamilton CW; Mallia-Hughes M
    Curr Med Res Opin; 2005 May; 21(5):703-4; author reply 704. PubMed ID: 15969869
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug development for the aquaculture industry: a perspective from the Center for Veterinary Medicine.
    Sundlof SF
    Vet Hum Toxicol; 1998; 40 Suppl 2():5-6. PubMed ID: 9823574
    [No Abstract]   [Full Text] [Related]  

  • 60. Compounded medicines and 'off label' prescribing - a case for more guidance.
    Fois RA; Mewes BT; McLachlan AJ; Ramzan I
    Aust Fam Physician; 2009; 38(1-2):16-20. PubMed ID: 19283230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.